Celebrating 10 Years of Progress
Now in its 10th year, CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.
Join us at the #1 Immunogenicity & Bioassay Event in the U.S.
Bringing Together Industry, Academia & Regulatory Authorities
EVENT FEATURES:
- 65+ Scientific Presentations & Case Studies, including FDA
- Roundtable Breakouts & Panel Discussions
- Dedicated Exhibit/Poster Hall
- "Track-hop" to Conferences Occurring on the Same Dates
- 250+ Global Delegates
View the 2018 Attendee ListTestimonials
“This conference provides very deep and broad scientific presentations, roundtable discussions, and excellent networking opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group Leader, Pfizer
“The Immunogenicity and Bioassay Summit covers up-to-date research and regulatory advances on all aspects of immunogenicity. It’s a very good meeting for experts and newcomers to the field.”
- Senior Director, Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire
“Program and participants first class.”
- Associate Director, Novo Nordisk
“Great to get regulatory perspectives on challenges and expectations. The higher level strategic discussions were very informative.”
- Beth Arnold, Director, Biologics & Vaccine Bioanalytics, Merck
“Breakout interaction with FDA experts was very valuable.”
- Associate Director, Alexion Pharmaceuticals Inc.
“The event has a great atmosphere for networking and learning about new expectations in our always changing field”
- Senior Group Leader, Immunogenicity, PPD, Inc.
“I really liked the wide and deep background provided by the highly specialized speakers. Everyone in the field should attend this."
- Post-Doctoral Fellow, Molecular Biology, National Cancer Institute
View more testimonials
Keynote & Featured Speakers
Rakesh Dixit, PhDVice President, R&D, Global Head, Biologics Safety AssessmentMedImmune, Inc.
Theresa Goletz, PhDGlobal Head NBE DDEMD Serono
William Hallett, PhDBiologist, OPQ/OBPCDER, FDA
Timothy Hickling, PhDImmunogenicity Sciences Lead, Biomedicine DesignPfizer, Inc.
Thomas Little, PhDPresident and CEO, Bioassay SciencesThomas A. Little Consulting
Timothy SchofieldSenior Advisor, Technical Research & DevelopmentGSK
Ethan Shevach, MDSenior Investigator, Laboratory of Immunology, National Institute of Allergy and Infectious DiseasesNIH
Perceval SondagSenior Manager, StatisticsPharmaLex
Joleen T. White, PhDDirector, Head of Project Support, NBE Drug DispositionEMD Serono
Contact Us
SPEAKER AND TOPIC SUGGESTIONS
Nicole Lyscom, PhD
Sr. Conference Director and Team Lead,
Cambridge Healthtech Institute
Phone: +44 1935 389498
Email: nlyscom@healthtech.com
SPONSORSHIP & EXHIBITS
Carolyn Cooke
Business Development Manager,
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: ccooke@healthtech.com